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Abstract
The NIAID (National Institute for Allergy and Infectious Diseases) Biodefense Proteomics program aims to identify targets for
potential vaccines, therapeutics, and diagnostics for agents of concern in bioterrorism, including bacterial, parasitic, and
viral pathogens. The program includes seven Proteomics Research Centers, generating diverse types of pathogen-host data,
including mass spectrometry, microarray transcriptional profiles, protein interactions, protein structures and biological
reagents. The Biodefense Resource Center (www.proteomicsresource.org) has developed a bioinformatics framework,
employing a protein-centric approach to integrate and support mining and analysis of the large and heterogeneous data.
Underlying this approach is a data warehouse with comprehensive protein + gene identifier and name mappings and
annotations extracted from over 100 molecular databases. Value-added annotations are provided for key proteins from
experimental findings using controlled vocabulary. The availability of pathogen and host omics data in an integrated
framework allows global analysis of the data and comparisons across different experiments and organisms, as illustrated in
several case studies presented here. (1) The identification of a hypothetical protein with differential gene and protein
expressions in two host systems (mouse macrophage and human HeLa cells) infected by different bacterial (Bacillus
anthracis and Salmonella typhimurium) and viral (orthopox) pathogens suggesting that this protein can be prioritized for
additional analysis and functional characterization. (2) The analysis of a vaccinia-human protein interaction network
supplemented with protein accumulation levels led to the identification of human Keratin, type II cytoskeletal 4 protein as a
potential therapeutic target. (3) Comparison of complete genomes from pathogenic variants coupled with experimental
information on complete proteomes allowed the identification and prioritization of ten potential diagnostic targets from
Bacillus anthracis. The integrative analysis across data sets from multiple centers can reveal potential functional significance
and hidden relationships between pathogen and host proteins, thereby providing a systems approach to basic
understanding of pathogenicity and target identification.
Citation: McGarvey PB, Huang H, Mazumder R, Zhang J, Chen Y, et al. (2009) Systems Integration of Biodefense Omics Data for Analysis of Pathogen-Host
Interactions and Identification of Potential Targets. PLoS ONE 4(9): e7162. doi:10.1371/journal.pone.0007162
Editor: Jo¨rg Hoheisel, Deutsches Krebsforschungszentrum, Germany
Received March 16, 2009; Accepted August 14, 2009; Published September 25, 2009
Copyright:  2009 McGarvey et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Supported by National Institutes of Allergy and Infectious Disease NIH Contract: HHSN266200400061C The funders had no role in study design,
analysis, decision to publish, or preparation of the manuscript. The funders, NIAID, did play some role in data collection as they had contracts with the Proteomics
Research Centers that provided the data. The contracts provided guidelines on data collection and submission to the Resource Center and require release to the
public. Social and Scientific Systems is an IT contractor and has no interest, finacial or otherwise, in the data, software or conclusions in this manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: pbm9@georgetown.edu (PBM); wuc@georgetown.edu (CHW)
Introduction
The NIAID (National Institute of Allergy and Infectious Diseases)
Biodefense Proteomics program, established in 2004, aims to
characterize the pathogen and host cell proteome by identifying
proteins associated with the biology of microbes, mechanisms of
microbial pathogenesis and host responses to infection, thereby
facilitating the discovery of target genes or proteins as potential
candidates for the next generation of vaccines, therapeutics, and
diagnostics [1]. The program includes seven Proteomics Research
Centers (PRCs) conducting state-of-the-art high-throughput re-
search on pathogens of concern in biodefense and emerging/
reemerging infectious diseases, as well as a Biodefense Resource
Center for public dissemination of the pathogen and host data,
biological reagents, protocols, and other project deliverables.
The PRCs work on many different organisms, covering bacterial
pathogens (Bacillus anthracis, Brucella abortus, Francisella tularensis,
Salmonella typhi, S. typhimurium, Vibrio cholerae, Yersinia pestis), Eukaryotic
parasites (Cryptosporidium parvum,Toxoplasma gondii), and viral pathogens
(Monkeypox, SARS-CoV, Vaccinia). The centers have generated a
heterogeneous set of experimental data using various technologies
loosely defined as proteomic, but encompassing genomic, structural,
immunology and protein interaction technologies, as well as more
standard cell and molecular biology techniques used to validate
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potential targets identified via high-throughput methods. In addition
to data, the PRCs have provided biological reagents such as clones,
antibodies and engineered bacterial strains, other deliverables include
standard operating procedures (SOPs) and new technologies such as
instrumental methods and software tools and finally publications
related to all of these activities.
Consequently, there were a number of unique challenges facing
the Resource Center: (i) how to coordinate with the seven PRCs
with various pathogens, technologies, processes, and data types; (ii)
how to provide seamless integration of three institutions that make
up the Resource Center; and (iii) how to provide timely and effective
dissemination of newly discovered information to the user
community. In particular, due to the breadth of the program, the
potential user community is quite broad, from technology or
informatics experts who may want to reanalyze the data or develop
better algorithms, to a wide group of biomedical scientists who are
interested in mining the data for their own studies or just finding
new information on a protein or gene of interest quickly and easily.
Accordingly, we developed a set of functional requirements early
in the Biodefense Resource Center development: (i) to implement a
center-specific submission protocol and data release plan for timely
dissemination, (ii) to promote data interoperability, adopting
common standards (such as HUPO Proteomic Standards Initiative
[2,3,4]), defining a core set of metadata with mapping to controlled
vocabularies and ontologies, recommending preferred IDs for gene/
protein mapping, and (iii) to provide value-added annotation to
capture key findings and integration of the data with related
resources for functional interpretation of the data. Available online at
http://proteomicsresource.org, the architecture, initial content and
general features of the Biodefense Proteomics Resource were briefly
described elsewhere [5]. A breakdown of the Resources content by
organism, PRC and other criteria can be seen at: http://www.
proteomicsresource.org/Resources/Catalog.aspx. Tutorials and
help are provided on the website: http://www.proteomicsresource.
org/Resources/Tutorials.aspx , http://proteininformationresource.
org/pirwww/support/help.shtml#30
The objective of this study is to provide a systems approach to the
study of pathogen-host interactions, connecting the various types of
experimental data on genomics, proteomics and host-pathogen
interactions with information on pathways, regulatory networks,
literature, functional annotation and experimental methods. Having
most of this information accessible in one place can facilitate
knowledge discovery and modeling of biological systems. Like many
problems in data integration, it is easy to know the general outline of
what we want, but often much harder to implement and navigate
the information, especially if the original data crosses disciplinary,
laboratory and institutional boundaries. Here we describe in detail a
protein-centric approach for systems integration of such a large and
heterogeneous set of data from the NIAID Biodefense Proteomics
program, and present scientific case studies to illustrate its
application to facilitate the basic understanding of pathogen-host
interactions and for the identification of potential candidates for
therapeutic or diagnostic targets. Several scientific use cases are
presented that illustrate how one can search varied experimental
data from different laboratories and even ones researching different
infectious organism and their hosts to make potentially useful
connections that could lead to new hypotheses and discoveries.
Methods
Biodefense Resource Center Infrastructure
Based on the functional requirements of the Resource Center, we
developed a bioinformatics infrastructure for integration of PRC
deliverables (Figure 1). In our workflow, multiple data types from
PRCs are submitted to the center using a data submission protocol
and standard exchange format, with the metadata using controlled
vocabulary whenever possible. For functional interpretation of the
data, we then map the gene and protein data based on identifier (ID)
mapping or if necessary using peptide or sequence mapping to
proteins in our data warehouse described below. All of the databases,
along with information on the PRCs and organisms under study are
listed in the proteomics catalog accessible from the web portal.
Protein-Centric Data Integration
The key design principal in the Resource Center is protein-centric
data integration. Here the diverse experimental data are integrated
and presented in a protein-centric manner where information is
queried and presented via common proteins and connected to
experimental data and the network of protein attributes, including
information on the encoding genes, protein families, pathways,
functions andmore. In practice a protein-centric approach works well
as proteins occupy a middle ground molecularly between gene and
transcript information and higher levels of molecular and cellular
structure and organization. Proteins are often the functional
molecules in biological processes described by pathways, molecular
interactions and other networks. Protein families, in turn, have
proven to be invaluable in studying evolution and for inferring and
transferring functional annotation across species.
Master Protein Directory
Underlying the protein-centric data integration is a data warehouse
called the Master Protein Directory (MPD) where key information is
extracted from the primary data and combined for rapid search,
display and analysis capabilities. The MPD is built on the data and
capabilities of iProClass [6] a warehouse of protein information, which
in turn is built around UniProtKB [7] but supplemented with
additional sequences from gene models in RefSeq [6] and Ensembl [7]
and additional annotation and literature from other curated data
resources such as Model Organism Databases [8,9,10,11,12,13] and
GeneRIF [14]. The biodefense data are essentially additional data
fields added to a subset of iProClass entries to create the MPD.
Currently the MPD defines and supports information from the
following types of data produced by the PRCs: Mass Spectrom-
etry, Microarray, Clones, Protein Interaction, and Protein
Structure. More data types or attributes may be added in the
future if needed. Supplemental table S1 shows the common and
unique fields used in the MPD for each data type. An advantage of
the data warehouse design is that, if needed, additional fields can
be extracted from the primary data and easily added as new
attributes without greatly altering the existing database design or
query mechanisms. The MPD data is stored in an Oracle database
along with iProClass data. For data exchange, an XML file and
schema for the current MPD are available for download at:
ftp://141.161.76.88/pub/proteomics_ftp/rc/MD_data/ipro-
class_mpd.dtd
ftp://141.161.76.88/pub/proteomics_ftp/rc/MD_data/ipro-
class_mpd.xml
ftp://141.161.76.88/pub/proteomics_ftp/rc/MD_data/ipro-
class_mpd.xsd
The MPD including the website and FTP files is updated every
3 weeks in conjunction with iProClass or whenever new PRC data
is released.
Protein Mapping Process
The various Proteomics Research Centers all used different sources
and identifiers for the nucleotide and protein sequences in their
analysis pipelines and occasionally would change sources depending
on the experiment. This is a common problem encountered when
Pathogen-Host Omics Data
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attempting to combine data across research laboratories unless
identical sequence databases, processes, platforms and organism
names are used. Examples of database identifiers used include
Genbank/EMBL/DDBJ accessions and locus tags, UniGene acces-
sions, RefSeq accessions, IPI accessions, NCBI gi numbers and IDs
unique to a sequencing center or organism-specific database. The first
step was to map all experimental results to a common representation
of a protein. This was achieved by mapping all protein and gene IDs
and names to iProClass proteins. The majority of the mapping using
IDs from public resources was done using mapping services and tables
provide on the Protein Information Resource (PIR) web site (http://
proteininformationresource.org/pirwww/search/idmapping.shtml) and
FTP site (ftp://ftp.pir.georgetown.edu/databases/iproclass/). However,
some mapping problems needed to be addressed either by auto-
mated rules, direct sequence comparisons or manual analysis and
annotation.
Problems and Solutions
Mapping difficulties fell into 4 categories: 1) One-to-many
mappings: a common problem, especially when eukaryotic host
proteins derived from alternate splicing or viral polyproteins are
involved. UniProtKB usually merges information on alternate splice
forms or polyproteins, which helped minimize this problem for our
purposes, but in cases where multiple mappings exist, we selected as
most informative the entry in the manually reviewed UniProtKB/
SwissProt section; if no SwissProt entry was found, the longer
sequence in UniProtKB/TrEMBL section was selected. Users could
always find the alternate mappings via the iProClass related
sequences link on the MPD entry page to precompiled BLAST
results on all iProClass sequences. 2)Retired sequences: genomic
sequences from databases such as RefSeq, IPI, or UniGene are not
static and, as information changes, some gene predictions and
translations are retired with each new build. Retired sequences often
required manual mapping by a curator to match original gene or
peptide results to current protein sequences. Primarily UniParc
(UniProt sequence archive) [15] was used for this purpose. 3)
Protein sequences not available in iProClass or any
public repository: this occurred most often with Toxoplasma
gondii whose genome sequencing was still in progress and stable
builds were not yet available. However, the problem also occurred
Figure 1. General infrastructure and information flow of the Biodefense Resource Center. The Master Protein Directory provides protein-
centric data integration, search and analysis capabilities. The Proteomics Catalog houses web pages with information on the PRCs, the NIAID
Proteomics Program and project related publications. The Proteomics Data Center contains complete experimental data and protocols for each PRC
data set in relational databases but is not integrated in the protein-centric manner. All databases are linked on the web.
doi:10.1371/journal.pone.0007162.g001
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in some well-characterized organisms like Vibrio cholera and Bacillus
anthracis. Several data sets contained information on annotated but
not translated pseudogenes. In the case of Vibrio cholera, 21 of 48
pseudogenes cloned and sequenced by the Harvard Institute of
Proteomics did not contain the annotated point mutation or frame
shift and appeared to produce full-length proteins [16]. In the case
of Bacillus anthracis, microarrays containing probes for 82 of 192
annotated pseudogenes also showed significant changes in RNA
expression in response to infection or other treatments [17,18,19].
In these cases, new database entries were created in the MPD to
house the results. 4) Alternate species or strain representations:
several experimental data sets reported sequence identifiers for
strains or variants other than the one used in the experimental
sample. This is not an uncommon situation as the genetically most
characterized variant is often an attenuated laboratory strain while
the more virulent strains are either not yet sequenced or the
sequence is of lower quality. Often microarray chips or mass
spectrometry databases are designed using the best available
sequence from the research strain, yet then use RNA and protein
samples from another similar virulent strain. The question here was
what organism strain to map to and represent on our website: the
strain the RNA or protein the sample came from, or alternatively,
the strain that matched the identifier and sequence used in the
research to detect the RNA or protein. For the MPD we chose to
map to the sequence identifier reported in the data files and related
publications, with the additional virulent strain information noted in
the results summary.
Search Design
Data Mining Design Goals. In consultation with NIAID
and PRCs within the project’s Interoperability Working Group,
we developed 3 goals for data mining. 1) All project data and other
deliverables should be available via browsing and simple keyword
searches. 2) The data and information provided by the resource
should be sufficient to allow a skilled researcher to download and
reanalyze or mine the data for additional information. 3) Our
target user was a biomedical scientist not expert in the technology
used to produce the data or in bioinformatics, thus the data,
procedures, publications and general results and conclusions of an
analysis should be relatively easy to find on the project website for
someone not familiar with the details of the particular technologies
used to generate it.
To allow both simple keyword searches and also Boolean
searches of the project data, we did the following: 1) We included
in the MPD only ‘‘validated’’ results that were determined by the
research centers to be significant using their methods. To do
otherwise would confuse users not familiar with the technology
and how results are filtered. Results that fell below the significance
threshold used by the research center were made available via
download of data sets at the FTP site. 2) ‘‘RAW’’ unprocessed
machine specific data would be stored by the PRC and available
on request. 3) To facilitate and simplify searches across
laboratories and data types, we omitted most data type or analysis
specific numerical values and statistics from the general MPD
search and display. These numerical values are usually platform,
laboratory and method dependent and cannot easily be used to
compare across datasets so including them might be confusing to
users. Instead, we focused on providing simple, yet powerful,
queries of experimental summaries where a user can query if a
gene/protein was presented in the results and, in some cases, if it
showed a reported increase or decrease in expression or
accumulation based on the PRC’s criteria. Once a set of proteins
of interest is identified, a user can then drill down to view the
specific experimental values and methods employed to generate
the particular dataset. Links to details in the publications are
provided and full data are available via FTP. Since all protein
attributes are included as search options, one can query beyond
simply protein names, accessions or project data and search
pathways, protein families, Gene Ontology (GO) terms, database
cross-references and many other attributes, providing many
powerful options to the users.
To provide a robust text search for the website, we used the PIR
text indexing system [20] in which over 100 text fields and unique
identifiers from the MPD database are indexed using Callable
Personal Librarian (CPL) [21] which supports fast exact text
search, substring & wildcard text search, range search and Boolean
searches. Entry indexing and retrieval is supported by Oracle.
I: Unstructured keyword search. A simple keyword search
was implemented on every page of the resource’s website. This
searches all fields in the MPD. To further facilitate searches, the
protein name field is supplemented by also searching the
BioThesaurus [10] containing all gene and protein name
synonyms and textual variants for each protein from over 35
data sources. In addition, the default option searches all text from
the PubMed abstract for all project publications, an abstract of
each technology and all text in SOPs. The text indexed for
publications, technologies and SOPs was annotated with
additional standard keywords to facilitate searches. Figure 2
shows the results of a simple keyword search with hits for proteins,
reagents, publications, technologies and SOPs.
II: Structured text search. The MPD database contains
over 100 fields derived from iProClass and Proteomics Research
Center’s data. Currently 75 of these fields are available for
individual searches and can be combined with Boolean operators
as seen in some of the use case examples in this paper.
The protein-centric search results are presented in a customizable
tabular format where users can add or delete columns. Currently 62
fields can be customized. The tabular display has two modes: 1) a
default mode which displays fields common to all the supported data
types and 2) a data type specific mode which restricts the results to a
particular data type and displays fields specific to that data type. See
supplemental table S1 for a list of data type specific fields. Additional
filters for Proteomic Research Center and Organism are available as
pull down menus to aid browsing and viewing the results of queries.
Examples of these functions are illustrated in the scientific use cases
below and in help pages and tutorials available on the website. http://
www.proteomicsresource.org/Resources/Tutorials.aspx, http://
proteininformationresource.org/pirwww/support/help.shtml#30.
Results
Data Base Content – Browsing Pathogen-Host Omics
Data
The resource currently contains information on 35,112 proteins
from 58 datasets, 35,819 reagents, 75 SOPs, 31 technologies and
88 manuscripts. Table 1 shows statistics on proteins in the MPD.
Currently ,30% of the proteins are uncharacterized in that they
are called either ‘‘Uncharacterized’’ or ‘‘Hypothetical’’ and have
no other functional annotations or functional domains. Of these
uncharacterized proteins, ,85% have experimental data, such as
mass spectrometry, microarray, or protein interactions, associated
with them. The remaining 15% of uncharacterized proteins are
available as full length clones for further research. Though the
program is focused on pathogen proteins, about 32% of the
proteins are host proteins from mouse or human, as cell lines or
tissue samples from both these organisms were used as infection
models for multiple pathogens.
Pathogen-Host Omics Data
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Web-based Protein Search – Searching Pathogen-Host
Omics Data
Simple Keyword Search. Due to the popularity of internet
searches, support of unstructured keyword queries, even for structured
data, has become critical for any web site. To support this feature, the
default protein-centric search returns results for all project deliverables,
data, reagents, protocols, technologies and publications. An example is
shown in Figure 2 where a single keyword search ‘‘bacillus anthracis’’
finds 10,988 pathogen and host proteins withMass spec, microarray or
protein interaction data and also 13,251 reagents in the Master
Reagent Directory (mostly ORF and Y2H clones andmutant bacterial
strains of Bacillus anthracis), 2 SOPs, 16 project publications and 2
technologies. The matched fields column allows users to refine their
queries and construct simple Boolean searches.
Biological Use Case Examples – Analyzing Pathogen-Host
Omics Data
Example I: Integrative Analysis. Structured fields allow
Boolean queries across organisms, data types and laboratories.
Figure 3 shows a query where we make use of the controlled
vocabulary in the ‘‘expression condition’’ field and searched for
common host proteins detected in studies of Bacillus anthracis and
Salmonella typhimurium infection in mouse macrophage cell lines.
Currently 222 proteins meet these criteria, mostly from mass
spectrometry studies by PNNL and the University of Michigan;
however, if we further restrict the search to include only those also
detected in microarray experiments, we find 16 proteins with mass
spec data from S. typhimurium infections at one research center, and
mass spec and microarray studies done using B. anthracis at another
research center. From the customizable results display shown in
Figure 3 we can view summary information on the proteins
detected. Full details on the protein and individual experimental
results are available via links [5].
Some benefits of the protein-centric mapping approach are
visible in the default display. 1) Minimizing redundancy, the
column PRC ID shows the different identifiers from different
databases used by the research centers. In the case of one protein
Q9WUA3/K6PP_MOUSE 6-phosphofructokinase type C (EC
2.7.1.11), a total of 9 identifiers from 4 different databases
Figure 2. Unstructured Keyword Query. A) The keyword ‘‘bacillus anthracis’’ hits results for project related proteins, SOPs, literature and
technologies. The query can then be refined further by using specific fields to form a structured query. Here the search is restricted to return only
proteins with interaction data. B) Multiple gene and protein IDs provided by the PRCs are merged into one representation of the protein. C) All data
types and experimental datasets from different centers are listed together. D) Matched fields are displayed to aid users in formulating queries. To
reproduce these queries use this URL: http://pir.georgetown.edu/cgi-bin/textsearch_cat.pl?search= 1&field0= all&query0 = bacillus+anthracis&an-
dor1 = and&field1=DATATYPE&query1 = interaction .
doi:10.1371/journal.pone.0007162.g002
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(Unigene, RefSeq, IPI, nr) were reported in the research results
that all represent either the gene or protein sequence for this single
mouse protein. 2) Discovery of additional experimental informa-
tion from other studies. Fifteen of the sixteen proteins found in the
query also have mass spec data from Caprion Proteomics, as
indicated in the ‘experiment’ column by Caprion_05, 06 and _10.
Caprion is studying Brucella abortus and using a similar mouse
macrophage model. Currently, only the data for uninfected
macrophages is available from Caprion. Additional data on
Brucella and mouse proteins from bacterial infected macrophages
should be included in future releases. From the results display, one
can follow links to view the iProClass protein report with executive
summaries of the results from the PRCs and information collected
from over 100 public resources or drill down to view the specific
peptides or expression values seen in these studies, read
publications and methods about the experiments or download
the data for additional analysis.
With a comprehensive protein data warehouse, one can also
broaden the search for relevant data and information from related
organisms using protein cluster or family information. In Figure 4
we illustrate this by selecting one protein, K1033_MOUSE, an
uncharacterized protein seen in three datasets from infected mouse
macrophages. Using the UniRef90 cluster ID [22] to query for all
proteins with at least 90% identity and no gaps, we find the human
homolog K1033_HUMAN was detected in HeLa cells infected
with vaccinia and monkypox virus. If we do a batch retrieval using
Uniref90 IDs from all 16 original mouse proteins, we find 12
human homologs were also detected in studies of orthopox
infection (not shown). The identification of a hypothetical protein
with differential gene and protein expressions in two host systems
(mouse macrophage and HeLa cells) infected by different bacterial
(Bacillus anthracis and Salmonella typhimurium) and viral (orthopox)
pathogens suggest that this protein should be prioritized for
additional analysis and functional characterization.
Example II: Combining data from different
studies. Discovering and comparing experimental results
across laboratories and data types can help lead to new
hypotheses for further experimentation [23,24,25]. Although
different laboratories use different sample preparation, detection
and analysis techniques making some direct comparisons difficult,
having the data together in one place allows queries and
comparisons between proteins and gene sets to be combined and
additional analysis undertaken.
In this example, data from different labs and data types are
combined for further analysis. A query of the MPD on data type
= ‘‘interaction’’ AND organism name = ‘‘virus’’ finds 33 vaccinia
virus proteins with interactions with human proteins determined
by Myriad Genetics. Browsing the results display shows that 25 of
the proteins were also seen in mass spec work published by PNNL
[26]. By combining the two experimental data sets Experiment =
‘‘MYRIAD_05’’ AND ‘‘PNNL_MS_09’’, we find 83 virus and
human proteins with both mass spec and interaction data from
each laboratory. Further investigation into the experimental
details shows that a protein interaction network was determined
by Myriad Genetics using a yeast-two hybrid assay to screen viral
bait proteins against a library of human prey proteins cloned from
different tissues. The mass spec data from PNNL was obtained
from viral preparations isolated from infected human HeLa cells.
The work from PNNL contained quantitative information in the
form of spectral counts and Accurate Mass Tag [27] intensities,
downloadable from the project FTP site. We combined all the
vaccinia plus human interaction data with peptide counts for each
protein and visualized the results using Cytoscape [28,29]. The
complete network of results is shown in Figure 5A.
Various methods have been tried and compared for filtering large
intra-species interaction networks to limit false positives and to select
the biologically relevant interactions [30,31,32,33,34,35]. Relatively
little has yet been done for inter-species pathogen-host networks.
Several common factors that have proved useful in other studies are
1) evaluating network hubs with many interactions and 2) using
correlations between interacting pairs with similar gene expression
patterns. For this small interactome, we looked for relatively
abundant proteins associated with multiple interactions. We
identified a single human protein interacting with three viral
proteins, three being the largest number of viral interactions seen
with a single host protein in this data set. The interactions are shown
in Figure 5B. The host protein Keratin, type II cytoskeletal 4
(P19013) interacts with three viral proteins (P11258 - 14 kDa fusion
protein, A27L; Q805H7 - Chemokine-binding protein C23/B29;
P17362 - Protein C6L). The 14 kDa fusion protein A27L is the most
abundant protein seen in this data set and participates in virus
penetration at during cell fusion [36,37]. A27L facilitates initial
attachment to cells by binding to glycosaminoglycans [38]. A27L is
found in all orthopoxviruses and has no cellular or entomopoxvirus
homologs. Additional viral proteins involved in attachment (D8L,
H3L) [39,40] and fusion (F9L, I2L) [41,42] were not observed. The
Chemokine-binding protein C23L belongs to a family of poxvirus
Table 1. Classification of MPD proteins.
Source Protein Count
All Organisms 35,112
Mus musculus (Mouse) 7,823
Toxoplasma gondii 6,678
Bacillus anthracis 5,854
Vibrio cholerae 3,732
Homo sapiens (Human) 3,526
Salmonella typhimurium 3,406
Salmonella typhi 2,061
Brucella abortus 944
Cryptosporidium parvum 609
Vaccinia virus 161
Monkeypox virus 130
Francisella tularensis 62
Yersinia pestis 75
Human SARS virus 6
Mass Spec Data 25,289
Microarray Data 7,031
Interaction Data 1,363
New Structures, (Domains) 6 (15)
Sequenced Clones 9,074
Uncharacterized Proteins 10,637
Proteins in Pathways 9,988
Classified in Families 24,953
With GO Terms 22,265
With Bioinformatics Resource Center Links 18,165
With Immune Epitope DB links 583
The content of the MPD as of July 2009. Numbers represent the total number of
proteins that meet the listed criteria, for example, have one or more GO term or
pathway or link associated with the protein.
doi:10.1371/journal.pone.0007162.t001
Pathogen-Host Omics Data
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chemokine-binding proteins that mimic the chemokine response
and prevent activation and chemotaxis of leukocytes [43,44].
Protein C6L belongs to a family of poxvirus paralogs that may
function as toll-like receptor inhibitors based on homology to A52R
[45,46,47]. Thus, this protein may modulate Toll/IL-1R signaling,
resulting in a diminished host immune response and enhancing viral
survival.
P19013 - Keratin, type II cytoskeletal 4, the host protein, has
tissue specificity in the suprabasal layer of the stratified epithelium
of the esophagus, exocervix, vagina, mouth and lingual mucosa,
and in cells and cell clusters in the mucosa and serous gland ducts
of the esophageal submucosa [48]. Transgenic knockout mice
have shown Keratin, type II cytoskeletal 4 to play an important
role in maintaining normal epithelial tissue structure [49]. Keratin
Figure 4. Queries on cluster or family information. Queries on cluster or family information can discover related information across laboratories
and host pathogen systems. Using the UniRef90 cluster ID for K1033_MOUSE, identified in Figure 3, to query for all proteins with at least 90% identity,
we find the human homolog K1033_HUMAN was detected in HeLa cells infected with Vaccinia and Monkypox virus [12].
doi:10.1371/journal.pone.0007162.g004
Figure 3. Structured queries across infectious agents and data types. A) Search for proteins detected in studies of Bacillus anthracis AND
Salmonella typhimurium infection that include microarray experiments, finds 16 host proteins from mouse macrophage cell lines. B) Results
include a large uncharacterized protein K1033_MOUSE. C) A customizable web interface allows users to add and view related information on
pathways of protein families. To reproduce these queries use this URL: http://pir.georgetown.edu/cgi-bin/textsearch_cat.pl?search = 1&field0 =
EXPC&query0= Infection+Bacillus+anthracis&andor1=and&field1= EXPC&query1= Infection+Salmonella+typhimurium&andor2=and&field2=datatype&
query2=microarray .
doi:10.1371/journal.pone.0007162.g003
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4 in human saliva has been shown to interact with the protein Srr-
1 localized on the surface of Streptococcus agalactiae and to play a
critical role in colonization of this bacterial pathogen [50,51].
Little is known about the mechanisms by which poxviruses
attach to and enter host cells. No receptor for virion attachment on
the host cell surface has been found. Poxvirus infection can occur
through interaction with human as well as mice airway epithelia,
[52,53] we propose that the protein interactions outlined above
may represent some of the initial interactions between host and
pathogen. Thus they represent potential therapeutic targets for
further investigation. This is the first report describing the
interaction of a poxvirus protein with a host Keratin, type II
cytoskeletal 4 protein.
Example III: Screening for Pathogen Specific Target
Proteins. Unequivocal identification of pathogens is important
so that adequate counter measures can be taken. Currently over
700 pathogenic and non-pathogenic bacteria have been
completely sequenced. The availability of sequence data allows
identification of proteins that are unique at different taxonomic
levels, thus providing a means to begin to distinguish pathogenic
from non-pathogenic species. However, if the initial screening
depends on sequence data alone, the list of potential targets for
laboratory validation can be relatively long; by supplementing
sequence results with experimental data one can prioritize the
target list for validation in the laboratory. We used such an
approach by computationally screening potential targets using
CUPID [54], PRC data and other computational means to
produce a list of potential targets.
Identifying species-specific proteins can be done with confidence
when multiple species and strains have been sequenced as is the
case with Bacillus anthracis. The approach relies on the fact that if a
gene is conserved over time within multiple strains it gives
confidence they will not be lost in the near future and hence are
ideal for diagnostic targets. These ‘‘core unique’’ proteins have
related sequences in all selected organisms (in this case all available
strains of Bacillus anthracis) but not in other related organisms. An
initial total of 327 proteins unique to the Bacillus anthracis proteome
were identified using the CUPID and UniProtKB version 13.0.
(Bacillus anthracis strain Ames isolate Porton, Bacillus anthracis strain
Ames ancestor, Bacillus anthracis strain Sterne were compared to
twelve other genomes in the Bacillus genus). The two closest
relatives of Bacillus anthracis as determined by CUPID are Bacillus
thuringiensis and Bacillus cereus. The species most closely related to
the selected organism is based on the best BLAST hits of its entire
Figure 5. Vaccinia virus, human protein interaction network. A) Triangular nodes represent Vaccinia proteins, round nodes human proteins.
Colors represent relative abundance as determined by peptide counts. Grey nodes represent no peptide data, green to yellow to orange to red
represent increasing spectral counts in the range of 3 to 543. B) The three interactions, discussed in the text. The host protein (Keratin, type II
cytoskeletal 4, UniProt: P19013) and three viral proteins (P11258 - 14 kDa fusion protein, A27L; Q805H7 - Chemokine-binding protein C23/B29;
P17362 - Protein C6L).
doi:10.1371/journal.pone.0007162.g005
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proteome [54]. One needs to be careful in choosing the diagnostic
targets that these two non-pathogenic organisms are not being
detected.
The initial list of 327 was refined to identify ‘‘core unique’’
proteins that are 100 amino acids or more in length. The 100
residue cutoff was used to ensure that the target list consisted of
proteins that are real (short proteins might not be real) and are
unique, as identification of homologs for short proteins is not
trivial [55]. This resulted in a list of 21 ‘‘core unique’’ proteins in
the pathogenic strains. It is possible that the proteins found may
have homologs in other organisms which were undetected by
CUPID because the genes were not annotated as open reading
frames To confirm their uniqueness, the 21 proteins were screened
for significant regions of similarity at the DNA level (either
pseudogenes or unannotated genes) using tBLASTn against the
NCBI nr database. Using NCBI’s nr which is produced
independently of similar, but not identical, sources as iProClass
also helps assure no sequences were missing from our warehouse.
This additional analysis resulted in a total of 10 Bacillus anthracis
specific proteins proposed as high-quality targets for development
of diagnostic probes. We then supplemented this information with
data from the PRC projects and Master Protein Directory to
create a matrix of information (Figure 6). Six of the ten targets
have data from the University of Michigan PRC showing that they
were differentially expressed in published microarray experiments.
Nine of the ten are available as clones produced by the Harvard
Institute of Proteomics. A search of all the microarray data from
the University of Michigan (using http://proteinbank.vbi.vt.edu/
ProteinBank/p/search/searchproteins.dll) showed that the four
proteins not differentially expressed (listed as clones only in
Figure 6) were still constitutively expressed well above background
in all studies (not shown). Either the proteins or the DNA coding
for these proteins can be used to develop and test pathogen
detection systems.
All the ‘‘core unique’’ proteins detected in this study lacked
meaningful functional annotation (i.e., were annotated simply as
‘‘uncharacterized protein’’), which is not surprising as such unique
proteins are not easy to characterize. One protein identified as a
target is a remnant of a prophage protein. Such proteins are well
known to be related to virulence [56]. Another protein is from the
pXO2 plasmid. A similar approach was taken for Salmonella species
using CUPID and public PRC data and several candidate
diagnostic proteins are currently being validated in the laboratory
(data not shown).
Discussion
A systems approach to biology or medicine requires the sharing,
integration and navigation of large and diverse experimental data
sets to develop the models and hypotheses required to make new
discoveries and to develop new treatments. To date this has most
often been done with selected research data or within an institution
or program where common instrumentation and methods make
standardization of experimental practices and data management
easier to achieve [57,58,59]. Alternative approaches require a
reanalysis of all the data by a common methodology as has been
done in some data repositories [60,61] or assigning some common
statistical metric to all data of a certain type to allow functional
coupling [62]. These approaches are all potentially useful, but
practically difficult to achieve on a large scale with heterogeneous
data. The protein-centric approach we employed is a relatively
simple, yet powerful and practical, approach to integrate and
Figure 6. Ten potential diagnostic markers for pathogenic strains of Bacillus anthracis. The prioritized protein list was obtained by
computationally screening potential targets using CUPID [54], PRC data and other computational means described in the text.
doi:10.1371/journal.pone.0007162.g006
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navigate diverse sets of omics data in a manner useful for systems
biology. Proteins are often the biologically functional elements in
cellular networks; thus, many types of data can be mapped to and
through proteins as a common biological object.
The lightweight data warehouse approach used for the MPD
proved useful in practice, especially with large datasets as its simple
design and schema allows greater flexibility to add new data types
and to modify search and analysis capabilities. Similar lightweight
approaches and schemas designed to optimize queries have been
shown useful in integration of genomic data [63,64]. The main
drawback of this approach is that the warehouse does not contain
all the data. However, this is rarely a problem if the data are
available in some other data resource optimized for that particular
data type and if some upfront analysis of the user’s needs for query
and analysis options is performed. For example, our use case
analysis suggested that for microarray and mass spectrometry data,
individual raw intensities, machine-specific parameters and most
calculated numerical values were not required for general queries
and analysis across the combined data as these values were only
comparable between the particular analysis performed in one lab.
As a result, most numerical values were not included in the MPD
for the default search but are accessible for display via hyperlinks
to our Protein Data Center or FTP site. However, if a new
attribute appear or users request searches on a particular value
omitted from the warehouse, adding it is a relatively simple matter
of adding new data columns. For instance, in example II our
combination and analysis of mass spectrometry and protein
interaction data, we could include peptide counts directly in the
MPD for immediate download instead of retrieving them from the
ftp files. Of course, no one approach can be perfect, as in biology
and research there always seems to be exceptions and new data
and multiple approaches need to be accommodated.
Efforts to standardize reporting requirements, vocabularies and
develop common XML data formats for sharing data are welcome
and can greatly ease the transfer and automated processing of a
particular data type. However the current standards do not
necessarily guarantee integration as the problems of reconciling
gene and protein identifiers as well as differences in experimental
methodology remain. We investigated and employed a few
common data standards and ontologies in developing the
Biodefense Proteomics Resource. We provided some data using
mzData [65] and MAGE-ML [66] but also provided original data-
specific text files for download. We found that several ontologies to
describe experimental methods were useful but incomplete and
focused on higher eukaryotes and thus did not yet contain terms
needed for microbial pathogens. Most useful was the Gene
Ontology [67] which has been widely adopted to annotate and
classify large scale results and can be used for searching and
classification in the MPD.
Here we have presented some unique examples to illustrate
benefits, as well as the difficulties, associated with integration of a
very diverse set of omics research data across different data types,
laboratories and organisms. We illustrated with three examples
how potential therapeutic and diagnostic targets can be identified
from integrated data applying relatively simple and established
tools and techniques. We continue to focus on data integration to
allow biologists to find relevant data sets for further detailed
analysis using the approaches and tools of their choice. In general
the analysis of diverse omics data is an area of active research and
a number of useful tools are under active development including
cytoscape [28], bioconductor [68] and galaxy [69]. In the future a
more seamless integration between data repositories and analysis
tools such as these would be the most useful approach to add
additional analysis options for integrated data.
Supporting Information
Table S1 Current fields in the Master Protein Directory.
Common and data type specific fields are listed. Description of a
field’s purpose and examples of some content are shown. All fields
are text strings. For more information see schema at ftp://141.
161.76.88/pub/proteomics_ftp/rc/MD_data/iproclass_mpd.xsd.
Found at: doi:10.1371/journal.pone.0007162.s001 (0.08 MB
RTF)
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